Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery
NCT02681679
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Cataract
Interventions
DRUG:
0.1% bromfenac ophthalmic solution
PROCEDURE:
femtosecond laser cataract surgery
Sponsor
Sun Yat-sen University
Collaborators
[object Object]